These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advances in the treatment of gram-negative bacterial meningitis. Romankiewicz N J Pract Nurs; 1984 Dec; 34(2):59-61. PubMed ID: 6444163 [No Abstract] [Full Text] [Related]
3. New drugs for enteric gram-negative bacillary meningitis in adults. Med Lett Drugs Ther; 1981 Aug; 23(17):73-4. PubMed ID: 6267438 [No Abstract] [Full Text] [Related]
5. What to do about the new penicillins and cephalosporins. Kunin CM Ohio State Med J; 1984 Apr; 80(4):315-6. PubMed ID: 6717885 [No Abstract] [Full Text] [Related]
6. Do we still need new oral antibiotics for community-acquired infections in pediatrics? Introduction. Adam D Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S5-6. PubMed ID: 7792128 [No Abstract] [Full Text] [Related]
7. A strategy for evaluating which of the new cephalosporins to use. Yogev R Pediatr Ann; 1986 Jun; 15(6):470-1, 474-7. PubMed ID: 3725440 [No Abstract] [Full Text] [Related]
8. The new cephalosporins for the treatment of bacterial meningitis in children and neonates. Bégué P G Ital Chemioter; 1985; 32(2):521-4. PubMed ID: 3833598 [No Abstract] [Full Text] [Related]
9. [Bacteriological, pharmacological and clinical study of cephazolin]. Tancrède C; Betourné C Nouv Presse Med; 1974 Apr; 3(0):34-7. PubMed ID: 4600178 [No Abstract] [Full Text] [Related]
10. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Harbarth S; Harris AD; Carmeli Y; Samore MH Clin Infect Dis; 2001 Nov; 33(9):1462-8. PubMed ID: 11588690 [TBL] [Abstract][Full Text] [Related]
11. [Review of oral cephalosporins. Basis for a rational choice]. Forti IN Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980 [TBL] [Abstract][Full Text] [Related]
12. The newest cephalosporins: how to use them? Ehrenkranz NJ; Hoffman TA J Fla Med Assoc; 1982 Oct; 69(10):863-4. PubMed ID: 6292322 [No Abstract] [Full Text] [Related]
13. Cefepime: the next generation? Sanders CC Clin Infect Dis; 1993 Sep; 17(3):369-79. PubMed ID: 8218678 [TBL] [Abstract][Full Text] [Related]
14. The third generation cephalosporins. Farber B; Moellering RC Bull N Y Acad Med; 1982 Nov; 58(8):696-710. PubMed ID: 6762896 [No Abstract] [Full Text] [Related]
15. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics. Burgess DS; Frei CR J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of bacterial infections with cephalexin]. Oclander G Bol Asoc Med P R; 1971 Feb; 63(2):41-8. PubMed ID: 5282745 [No Abstract] [Full Text] [Related]
17. The choice of antibacterial drugs. Med Lett Drugs Ther; 1996 Mar; 38(971):25-34. PubMed ID: 8598824 [No Abstract] [Full Text] [Related]
18. [20 years of cephalosporins]. Heilmann FG; Vreede RW Ned Tijdschr Geneeskd; 1985 Feb; 129(8):342-6. PubMed ID: 3982532 [No Abstract] [Full Text] [Related]
19. Choice of cephalosporins. Med Lett Drugs Ther; 1983 Jun; 25(637):57-60. PubMed ID: 6855695 [No Abstract] [Full Text] [Related]
20. [Pharmacokinetics and therapeutic experiences with a new cephalosporin derivative: cefazoline]. Lode H; Hendrischk A; Gebert S Verh Dtsch Ges Inn Med; 1974; 80():1541-3. PubMed ID: 4217984 [No Abstract] [Full Text] [Related] [Next] [New Search]